| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Cytarabine | GDSC1000 | pan-cancer | AAC | 0.18 | 3e-07 |
| mRNA | CEP-701 | GDSC1000 | pan-cancer | AAC | 0.13 | 0.0001 |
| mRNA | AZD7762 | GDSC1000 | pan-cancer | AAC | 0.12 | 0.0002 |
| mRNA | 17-AAG | GDSC1000 | pan-cancer | AAC | 0.11 | 0.0007 |
| mRNA | rTRAIL | GDSC1000 | pan-cancer | AAC | 0.1 | 0.003 |
| mRNA | VNLG/124 | GDSC1000 | pan-cancer | AAC | 0.094 | 0.004 |
| mRNA | Bosutinib | GDSC1000 | pan-cancer | AAC | 0.097 | 0.004 |
| mRNA | dabrafenib | GDSC1000 | pan-cancer | AAC | 0.086 | 0.004 |
| mRNA | AZ628 | GDSC1000 | pan-cancer | AAC | 0.14 | 0.005 |
| mRNA | lapatinib | CCLE | pan-cancer | AAC | -0.13 | 0.005 |